| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.0067 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |